PRC2-INHIBITOREN
Patent europeic · EP4043466 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP4043466
- Numer da la dumonda
- EP22165237
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 29-01-2019
- Publitgà
- 17-08-2022
- Concedì
- 21-08-2024
- La protecziun finescha il pli tard
- 28-01-2039
- Proxima taxa annuala scadenta
- 31-01-2027
- Classas IPC
- C07D 487/04 (2006.01)A61P 35/00 (2006.01)A61K 31/519 (2006.01)
- Prioritad
- US 201862624176 P 31.01.2018US 201862672701 P 17.05.2018US 201862747736 P 19.10.2018
- Derivà da
- EP19710816
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-02-2026
Midada
Published in Swissreg on 01.02.2026
- 02-07-2025
Midada
Published in Swissreg on 02.07.2025
- 01-02-2025
Midada
Published in Swissreg on 01.02.2025
- 29-10-2024
Adressa dal possessur midada
- Owner
- Mirati Therapeutics, Inc., 3545 Cray Court, San Diego, CA 92121, USA → Mirati Therapeutics, Inc., Route 206 and Province Line Road, Princeton, New Jersey 08543, USA
Published in Swissreg on 29.10.2024
- 19-09-2024
Represchentant inscrit
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 19.09.2024
- 21-08-2024
Concedì
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 21.08.2024
Partidas
Represchentant
Inventur
Del Mar 92014, US
San Diego 92111, US
San Diego 92130, US
San Diego 92130, US
San Diego 92128, US
San Diego 92127, US
San Diego 92122-4647, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.